Category HNE LHD

NSW (CEC) Paediatric (including neonatal sepsis) empiric antibiotic treatment links updated

These original links referenced via the HNE Guidelines page had broken and have now been corrected.  

Do you care for patients with Cystic Fibrosis?

A new HNE LHD Guideline for antibiotic use in cystic  fibrosis lung disease is now available.  

Are you ready for Antibiotic Awareness Week?

Antibiotic Awareness Week runs from the 16-22th of November. It is a time for all hospital staff and patients to think about the importance of antibiotics and what a difference they have made to our lives. Antibiotic Awareness Week is an international initiative that is supported locally by the CEC. This years theme is “Preserve […]

HNE Guidelines available on Smartphones

The HNEQUM mobile website has recently been updated to include the latest version of some commonly used guidelines.

National shortage of intravenous ampicillin (and amoxycillin)- HNE LHD advice sheet

Situation              HNE LHD ampicillin shortage fact sheet 2015 There is a global stock shortage of all intravenous (IV) ampicillin (and amoxycillin), with no clear indication as to when this shortage will be resolved. The shortage does not currently affect the supply of oral formulations, which are still available. Recommendations Where […]

Essential clinical care of Staphylococcus aureus bloodstream infection (SAB)

Updated 8/5/20. A. Healthcare-associated events (2018, HNE LHD ) 60 healthcare-associated SAB cases occurred with 7% due to methicillin-resistant Staphylococcus aureus (MRSA) and age-adjusted 30 day mortality of 9%. SAB relapse within 15-90 days occurred in 2.1% of adult events 7% of paediatric events. Principle sites common: ● Vascular access device (e.g. intravenous cannula, central […]

Managing patients with asplenia and hyposplenia

People who have had a splenectomy or have poorly functioning spleens are at higher risk of infection. These patients require education about early identification of infections and may require additional immunisations or prophylactic antibiotics. Spleen Australia is an organisation in Melbourne that provides resources to both patients and health professionals for dealing with absent or poorly functioning […]

Community Acquired Pneumonia – updated HNELHD Guideline

The updated Hunter New England guideline,  Adult Community Acquired Pneumonia: Initial Investigation and Empiric Antibiotic Therapy has now been released. Community acquired pneumonia (CAP) is a common cause of hospital admission, carrying a significant risk of morbidity and mortality.  Approximately 1/3 of patients require admission to hospital.  Streptococcus pneumoniae remains the commonest pathogen ( see here for […]

Australian National Antimicrobial Resistance Strategy: Objective Seven, Governance- What does it mean for HNE?

The final objective Seven of the Australian strategy focuses on strengthening AMS governance at local, regional and national levels to ensure leadership, engagement and accountability for actions taken to combat antimicrobial resistance. A coordinated effort from a wide range of participants is required.  Engaging participants at the frontline of antibiotic prescribing will be an important step in meeting these objectives. Priority […]

Australian National Antimicrobial Resistance Strategy: Objective Six, Collaboration- What does it mean for HNE?

Objective Six of the  Australian strategy aims to strength international partnerships and collaboration on this global issue. The global movement of people, food, animals and other products facilitates spread of resistant pathogens. Growth of medical tourism enables spread of healthcare-acquired infections or MRO colonisation between hospitals in different countries. International collaboration is essential . Priorities include: Active engagement with multilateral organisations, such as […]